The information on this page comes from the UK Activity Report.
Click here for further details

Galen Warner Chilcott, the pharmaceuticals group formerly known as Galen, has received a £1.5bn takeover approach from three US private equity firms. 21-Sep-2004 Galen is to acquire a pharmaceuticals manufacturing facility in Puerto Rico from Pfizer, in order to reduce its reliance on third parties for the production of its existing products. 05-May-2004 Galen has sold its UK-based pharmaceutical sales and marketing operation to its founder for £40m, and has also announced the sale of its sterile fluids solutions business to Gambro BCT of the US for £2.5m. 30-Apr-2004 Galen Holdings has sold its Pharmaceutical Development and Manufacturing Services business to the company's founder and former Chairman for £20m. 03-Dec-2003 Galen is to spend £310m on the acquisition of three women's healthcare products from Pfizer of the US, which will increase its turnover by two-thirds. 07-Mar-2003 Galen has announced the £10m sale of its Interactive Clinical Technologies business to its founder, who also acquired the main clinical trials operation in May. 26-Aug-2002 Galen is to sell its clinical trials business to its founder for £130m, in order to focus on pharmaceuticals production. 09-May-2002 Galen has bought two dermatology products - Moisturel and Duricef - from Bristol-Myers Squibb of the US for £28m. 29-Mar-2002 Galen is selling Chemical Synthesis Services, a small-scale drug manufacturing business with 110 staff in Northern Ireland, to its founder for £25m. 11-Jan-2002 Galen is to raise £300m in a share offer, and some of the proceeds will be used to fund the £67m purchase of the Estrace oestrogen replacement product from Bristol Myers Squibb. 03-Jul-2001 Galen is considering a number of potential sites for a new £10m research and development centre in Northern Ireland, which will create up to 100 jobs, and is also due to start work on a new manufacturing plant at Ardee in Co Louth next month. 05-Apr-2001 Galen is looking to expand its pharmaceuticals business in continental Europe and the US, but its services division, which prepares medicines for clinical trials, is now regarded as non-core. 07-Feb-2001 Galen is looking to spend up to £700m on acquisitions to expand its pharmaceuticals business, and is particularly interested in US companies, small biotechnology groups and companies with a European salesforce. 29-Nov-2000 Galen is to acquire Warner Chilcott, the US supplier of women's health products, for £190m. 05-May-2000 Galen has raised £37m in a share placing, and some of the cash will be used to acquire small pharmaceutical companies. 26-Nov-1999 Galen is to create a further 300 jobs at its pharmaceutical sites in Craigavon and Larne over the next three years, in a £40m investment. 17-Nov-1999 Galen is to acquire the product range of Bartholemew Rhodes, the Northamptonshire-based pharmaceutical company, for £20m. 08-Jun-1999 Galen has announced plans for a £21m expansion of its pharmaceutical activities in Northern Ireland, which will lead to 63 new jobs at its Craigavon headquarters and 40 jobs in its SynGal division. 03-Feb-1999 Galen, the Irish drugs company, has ended merger discussions with Ferring Pharmaceuticals of the Netherlands due to current market conditions. 13-Oct-1998 Galen Holdings of Ireland is discussing plans for a reverse takeover by Ferring, the Dutch pharmaceuticals concern, which would give it access to Ferring's international sales network. 24-Jun-1998 Galen, the pharmaceuticals concern, is planning to float on the stock market in order to raise about £20m to fund the expansion of its Clinical Trials Supplies business and set up a chemical synthesis facility near Belfast. 19-May-1997 Galen Holdings, the pharmaceuticals concern, has announced a £17m expansion in Northern Ireland, creating 160 jobs. 24-Nov-1995 The information on this page comes from the UK Activity Report. Click here for further details Copyright UK Business Park 1995-2009